Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Maintenance Therapy Using Lenalidomide in Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31]
- Status
- UNKNOWN
- Phase
- PHASE2
A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Lenalidomide for Patients With Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2